Status:
COMPLETED
Ketoprofen With or Without Vaginal Isonicotinic Acid Hydrazide Prior to Hysterosalpingography
Lead Sponsor:
Aswan University Hospital
Conditions:
Infertility, Female
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
The aim of our study is to determine the efficacy of Ketoprofen with or without vaginal isonicotinic acid hydrazide on the pain scores during HSG.
Detailed Description
hysterosalpingography can cause pain and discomfort in several ways: Use of the tenaculum to grasp the cervix and straighten the uterus for proper insertion; trans-cervical actions including measuring...
Eligibility Criteria
Inclusion
- any patient came for Hysterosalpingography
Exclusion
- any patient has contraindication to HSG
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04500470
Start Date
September 1 2020
End Date
September 1 2021
Last Update
January 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aswan University Hospital
Aswān, Egypt, 81528